Switching from a Non-Protease inhibitor-Based Regimen To the Fixed Dose Combination of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Clinical Practice.
Saved in:
| Title: | Switching from a Non-Protease inhibitor-Based Regimen To the Fixed Dose Combination of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Clinical Practice. |
|---|---|
| Authors: | Ranzenigo M; Vita-Salute San Raffaele University, Milan, Italy.; Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy., Gianotti N; Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy., Galli L; Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy., Poli A; Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy., Mastrangelo A; Vita-Salute San Raffaele University, Milan, Italy.; Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy., Bruzzesi E; Vita-Salute San Raffaele University, Milan, Italy.; Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy., Chiurlo M; Vita-Salute San Raffaele University, Milan, Italy.; Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy., Nozza S; Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy., Bossolasco S; Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy., Spagnuolo V; Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy., Mancusi D; Medical Affairs Department, Infectious Disease and Vaccines & PAH, Janssen-Cilag SpA, Cologno Monzese, Italy., Termini R; Medical Affairs Department, Infectious Disease and Vaccines & PAH, Janssen-Cilag SpA, Cologno Monzese, Italy., Carini E; Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy., Lazzarin A; Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy., Castagna A; Vita-Salute San Raffaele University, Milan, Italy.; Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy. |
| Source: | Drug design, development and therapy [Drug Des Devel Ther] 2022 Jun 27; Vol. 16, pp. 1975-1982. Date of Electronic Publication: 2022 Jun 27 (Print Publication: 2022). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Dove Press Limited Country of Publication: New Zealand NLM ID: 101475745 Publication Model: eCollection Cited Medium: Internet ISSN: 1177-8881 (Electronic) Linking ISSN: 11778881 NLM ISO Abbreviation: Drug Des Devel Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1177-8881 |
|---|---|
| DOI: | 10.2147/DDDT.S358976 |
